The earnings call highlighted significant growth in admissions and revenue in both the home health and hospice segments. There were also notable improvements in cost efficiency and financial performance. However, there were challenges such as a decline in total home health census and a year-over-year decrease in consolidated revenue. Branch closures were also a concern. Overall, the positive aspects of growth and financial improvements slightly outweigh the negative aspects.

Company Guidance -

Q3 2025

During Enhabit Home Health & Hospice's first quarter 2025 earnings call, several key performance metrics and strategic initiatives were highlighted. The company reported an 8.1% increase in admissions from Q4 2024 to Q1 2025, with fee-for-service admissions growing by 4% sequentially. Year-over-year admission growth normalized for Leap Year and branch closures was up 2.5%. Total home health census increased by 3.7% sequentially, despite a 2.4% year-over-year decline due to a low entry point in January. Non-Medicare admissions rose by 7.4% year-over-year, driven by payer innovation contracts, which accounted for 44% of non-Medicare visits in Q1 2025, up from 38% in Q1 2024. This shift contributed to a 7.6% increase in non-Medicare revenue per visit. Visits per episode decreased by 6.7% to 13.9%. In the hospice segment, admissions grew by 8% year-over-year, and the average daily census increased by 12.3%. The company also reported a 310 basis point improvement in referral-to-admission conversion year-over-year. Additionally, Enhabit completed the transition to outsourced coding resources, estimated to save $1.5 million in 2025, and closed or consolidated seven branches, with four more closures planned by the end of Q2 2025. The company reaffirmed its 2025 guidance based on strong Q1 results and business momentum.

Home Health Admissions Growth

Admissions increased by 8.1% from Q4 to Q1, with fee-for-service growing 4% sequentially. Year-over-year admission growth was up 0.7% and normalized growth was 2.5%.

Growth in Non-Medicare Revenue

Non-Medicare admissions increased by 7.4% year-over-year, driven by payer innovation contracts. Non-Medicare revenue per visit improved by 7.6% year-over-year.

Hospice Segment Performance

Total admissions grew 8% year-over-year with 5.2% same-store growth. Census grew by 12.3% with 10.6% same-store growth.

Cost Efficiency Improvements

Cost per day decreased by 0.8% year-over-year and 2.7% sequentially in the hospice segment. Completed transition to outsourced coding resource expected to save $1.5 million for 2025.

Financial Performance

Home health segment EBITDA improved by 7.9% sequentially. Hospice segment EBITDA grew by 65% year-over-year. Q1 2025 leverage ratio improved to 4.4x.

Balance Sheet and Cash Flow

Generated approximately $17 million of free cash flow and reduced overall bank debt by $25 million in the quarter.

Enhabit, Inc (EHAB) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

EHAB Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	- / -	0.03	―	―	―
Aug 06, 2025	2025 (Q2)	0.10 / 0.10	0.07	42.86% (+0.03)	―	―
May 07, 2025	2025 (Q1)	0.06 / 0.10	0.07	42.86% (+0.03)
Mar 05, 2025	2024 (Q4)	0.05 / 0.04	0.06	-33.33% (-0.02)
Nov 06, 2024	2024 (Q3)	0.04 / 0.03	0.03	0.00% (0.00)
Aug 06, 2024	2024 (Q2)	0.06 / 0.07	0.04	75.00% (+0.03)
May 08, 2024	2024 (Q1)	0.05 / 0.07	0.09	-22.22% (-0.02)
Mar 06, 2024	2023 (Q4)	0.03 / 0.06	0.32	-81.25% (-0.26)
Nov 07, 2023	2023 (Q3)	0.06 / 0.03	0.19	-84.21% (-0.16)
Aug 09, 2023	2023 (Q2)	0.14 / 0.04	0.47	-91.49% (-0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

EHAB Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 07, 2025	$8.20	$9.69	+18.17%
Mar 05, 2025	$8.54	$8.02	-6.09%
Nov 06, 2024	$7.91	$7.92	+0.13%
Aug 06, 2024	$9.89	$8.50	-14.05%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Enhabit, Inc (EHAB) report earnings?

Enhabit, Inc (EHAB) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Enhabit, Inc (EHAB) earnings time?

Enhabit, Inc (EHAB) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is EHAB EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing